3F-NEH
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H20FNO |
| Molar mass | 237.318 g·mol−1 |
| 3D model (JSmol) | |
| |
3F-NEH (3-Fluoro-N-Ethylhexedrone) is a recreational designer drug from the substituted cathinone family, with stimulant effects. It was first identified in Sweden in October 2020.[1]
See also
- 3-Fluoromethamphetamine
- 3-Fluoromethcathinone
- 3F-NEB
- 3F-PiHP
- 3F-PVP
- 3F-Phenmetrazine
- N-Ethylhexedrone
- N-Ethylhexylone
References
- ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.